Educational, research-use-only content. This article summarizes published scientific literature for informational purposes only and is not medical advice. The compounds discussed are supplied strictly for in-vitro laboratory research and are not approved for human or veterinary use.

What is DSIP?

Delta sleep-inducing peptide (DSIP) is a small naturally occurring neuropeptide first identified for its association with delta-wave (deep) sleep activity in early animal research. It has been studied as a tool in neuroscience and physiology (Pollard & Pomfrett, 2001).

What the research examined

The DSIP literature is older and exploratory, spanning sleep regulation, stress responses, and anaesthesia- and anticonvulsant-related contexts. Reviews note that despite decades of interest, DSIP’s precise mechanism of action and physiological role remain incompletely understood (Pollard & Pomfrett, 2001).

The limits of the current evidence

  • Much of the supporting work is decades old, heterogeneous, and not confirmed by modern controlled clinical trials.
  • DSIP is not an approved medicine; this material is supplied for in-vitro laboratory research use only.

References

According to PubMed:

  1. Pollard BJ, Pomfrett CJ. Delta sleep-inducing peptide. Eur J Anaesthesiol. 2001. doi:10.1046/j.1365-2346.2001.00917.x
Disclaimer: This content is educational only and reflects published research. It is not medical advice and makes no claim regarding the diagnosis, treatment, cure, or prevention of any disease. Products referenced are for in-vitro laboratory research use only (RUO); they are not for human or veterinary use. Where a compound has regulatory approval, that approval applies only to specific medical indications under professional supervision, not to the research material sold here.

Related Posts